Yttrium y-90 ibritumomab tiuxetan

DB32139Approved

Yttrium y-90 ibritumomab tiuxetan: Overview.

Mechanism
Curator reviewed
Also known as
(90)y-ibritumomab Tiuxetan · 90y Ibritumomab Tiuxetan · Ibritumomab tiuxetan (90Y) · Ibritumomab Tiuxetan Y-90 · Ibritumomab Tiuxetan Yttrium Y-90

Resolves to

Compound
UNIIQA846JAV5B
Clinical / RWD
ATCV10XX02
Targets
P11836MS4A1

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
14Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1ATC codeIncluding every combination product, plus 2 drug categories
Sign in
15+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Yttrium y-90 ibritumomab tiuxetan, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In